Mayne Pharma Group(MAYNF)
$2.37+0.01 (+0.21%)
MAYNF
Mayne Pharma Group financials statements
$2.37
At close:+0.01 (+0.21%)
Mayne Pharma Group (MAYNF) Ratios
24 Followers
Mayne Pharma Group Ratios
MAYNF's free cash flow for Q4 2026 was AU$22.05M. For the 2026 fiscal year, MAYNF's free cash flow was decreased by AU$-1.64M and operating cash flow was AU$23.68M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.31 | 1.35 | 1.47 | 1.78 | 0.81 |
| Quick Ratio | 1.09 | 1.16 | 1.23 | 1.51 | 0.64 |
| Cash Ratio | 0.32 | 0.23 | 0.35 | 0.33 | 0.15 |
| Solvency Ratio | 0.17 | -0.04 | -0.15 | 0.30 | -0.30 |
| Operating Cash Flow Ratio | 0.06 | 0.07 | -0.05 | -0.14 | -0.03 |
| Short-Term Operating Cash Flow Coverage | 0.38 | 0.50 | -4.01 | -3.99 | -0.04 |
| Net Current Asset Value | AU$ -179.03M | AU$ -291.53M | AU$ -228.40M | AU$ -60.15M | AU$ -253.27M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.04 | 0.03 | 0.04 | 0.32 |
| Debt-to-Equity Ratio | 0.11 | 0.11 | 0.09 | 0.07 | 0.76 |
| Debt-to-Capital Ratio | 0.10 | 0.10 | 0.08 | 0.07 | 0.43 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.07 | 0.04 | 0.00 |
| Financial Leverage Ratio | 2.33 | 2.74 | 2.52 | 1.97 | 2.39 |
| Debt Service Coverage Ratio | 0.53 | 1.01 | -11.20 | -11.36 | -0.37 |
| Interest Coverage Ratio | -6.46 | -4.71 | -29.58 | -17.83 | -10.58 |
| Debt to Market Cap | 0.19 | 0.09 | 0.10 | 0.11 | 1.00 |
| Interest Debt Per Share | 0.61 | 0.58 | 0.55 | 0.71 | 5.23 |
| Net Debt to EBITDA | -1.33 | -0.39 | 0.61 | 0.28 | -4.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.10% | 60.59% | 56.30% | 14.62% | 15.11% |
| EBIT Margin | -8.94% | -5.40% | -47.76% | -141.21% | -85.31% |
| EBITDA Margin | 7.66% | 11.57% | -30.12% | -105.57% | -50.20% |
| Operating Profit Margin | -8.94% | -5.78% | -35.83% | -101.56% | -77.56% |
| Pretax Profit Margin | 9.32% | -20.41% | -48.97% | -146.91% | -92.64% |
| Net Profit Margin | 6.38% | -22.99% | -44.89% | 63.87% | -179.00% |
| Continuous Operations Profit Margin | 8.13% | -22.07% | -43.44% | -172.91% | -140.05% |
| Net Income Per EBT | 68.44% | 112.65% | 91.66% | -43.47% | 193.21% |
| EBT Per EBIT | -104.30% | 353.05% | 136.69% | 144.65% | 119.45% |
| Return on Assets (ROA) | 2.69% | -9.25% | -15.24% | 9.39% | -21.59% |
| Return on Equity (ROE) | 6.26% | -25.34% | -38.36% | 18.48% | -51.53% |
| Return on Capital Employed (ROCE) | -5.28% | -3.13% | -16.77% | -19.89% | -18.09% |
| Return on Invested Capital (ROIC) | -4.33% | -2.98% | -14.74% | -19.59% | -11.27% |
| Return on Tangible Assets | 5.48% | -19.86% | -30.32% | 18.59% | -32.96% |
| Earnings Yield | 10.97% | -23.71% | -47.16% | 32.80% | -69.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.18 | 2.48 | 2.01 | 0.88 | 0.61 |
| Payables Turnover | 7.58 | 5.32 | 8.13 | 4.89 | 2.10 |
| Inventory Turnover | 3.45 | 3.18 | 2.27 | 1.90 | 1.22 |
| Fixed Asset Turnover | 6.96 | 6.93 | 7.28 | 3.57 | 0.70 |
| Asset Turnover | 0.42 | 0.40 | 0.34 | 0.15 | 0.12 |
| Working Capital Turnover Ratio | 4.48 | 3.42 | 1.99 | 2.94 | 4.12 |
| Cash Conversion Cycle | 224.71 | 193.33 | 297.37 | 534.55 | 727.30 |
| Days of Sales Outstanding | 167.08 | 147.24 | 181.70 | 416.56 | 603.25 |
| Days of Inventory Outstanding | 105.79 | 114.75 | 160.59 | 192.57 | 297.98 |
| Days of Payables Outstanding | 48.16 | 68.66 | 44.92 | 74.58 | 173.94 |
| Operating Cycle | 272.87 | 261.99 | 342.29 | 609.13 | 901.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.20 | 0.22 | -0.19 | -0.53 | -0.20 |
| Free Cash Flow Per Share | 0.16 | 0.07 | -0.45 | -3.23 | -0.35 |
| Dividend Paid and CapEx Coverage Ratio | 5.30 | 1.42 | -0.73 | -0.16 | -1.40 |
| Capital Expenditure Coverage Ratio | 5.30 | 1.42 | -0.73 | -0.20 | -1.40 |
| Operating Cash Flow Coverage Ratio | 0.36 | 0.42 | -0.39 | -0.91 | -0.04 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.04 | -0.04 | -0.23 | -0.11 |
| Free Cash Flow Yield | 5.68% | 1.31% | -9.79% | -73.49% | -7.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.00 | -4.39 | -2.12 | 3.05 | -1.44 |
| Price-to-Sales (P/S) Ratio | 0.58 | 0.97 | 0.95 | 1.95 | 2.59 |
| Price-to-Book (P/B) Ratio | 0.57 | 1.07 | 0.81 | 0.56 | 0.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.60 | 76.20 | -10.22 | -1.36 | -14.27 |
| Price-to-Operating Cash Flow Ratio | 14.28 | 22.65 | -24.15 | -8.29 | -24.45 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 0.09 | 0.05 | 0.25 | -0.04 |
| Enterprise Value Multiple | 6.26 | 7.98 | -2.55 | -1.56 | -9.16 |
| Enterprise Value | 183.99M | 377.13M | 298.19M | 303.27M | 722.82M |
| EV to EBITDA | 6.26 | 7.98 | -2.55 | -1.56 | -9.16 |
| EV to Sales | 0.48 | 0.92 | 0.77 | 1.65 | 4.60 |
| EV to Free Cash Flow | 14.52 | 72.62 | -8.25 | -1.15 | -25.39 |
| EV to Operating Cash Flow | 11.78 | 21.59 | -19.49 | -7.03 | -43.50 |
| Tangible Book Value Per Share | -0.90 | -2.17 | -1.44 | 0.21 | 1.09 |
| Shareholders’ Equity Per Share | 4.89 | 4.68 | 5.70 | 7.81 | 6.72 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | -0.08 | 0.11 | -0.18 | -0.51 |
| Revenue Per Share | 4.80 | 5.16 | 4.88 | 2.26 | 1.93 |
| Net Income Per Share | 0.31 | -1.19 | -2.19 | 1.44 | -3.46 |
| Tax Burden | 0.68 | 1.13 | 0.92 | -0.43 | 1.93 |
| Interest Burden | -1.04 | 3.78 | 1.03 | 1.04 | 1.09 |
| Research & Development to Revenue | 0.05 | 0.05 | 0.05 | 0.09 | 0.08 |
| SG&A to Revenue | 0.54 | 0.62 | 0.14 | 0.32 | 0.34 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.04 | 0.03 |
| Income Quality | 0.50 | -0.19 | 0.09 | 0.14 | 0.08 |
Currency in AUD
